Literature DB >> 8963386

Low density lipoprotein receptors and polyamine levels in human colorectal adenocarcinoma.

M Notarnicola1, M Linsalata, M G Caruso, A Cavallini, A Di Leo.   

Abstract

The low density lipoprotein receptor (LDLR) is a cell surface protein that binds with LDL, providing the cell with cholesterol for new membrane synthesis. Rapidly growing cells have high numbers of LDLRs, and these proteins have also been detected in neoplastic samples of human colorectal mucosa. Polyamines, putrescine, spermidine, and spermine, play an important role in cellular growth, and studies on colorectal cancers have demonstrated higher polyamine levels in neoplastic mucosa samples than in surrounding mucosa. The aim of this study was to investigate LDLR and polyamine levels in the neoplastic tissue of 43 patients (28 males and 15 females) with colorectal adenocarcinoma, using enzymatic immunoassay and high performance liquid chromatography, respectively. Specimens of neoplastic mucosa were considered LDLR-positive or LDLR-negative when the amount of bound human anti-LDLR antibody detected was equal or higher or lower than the cut-off value (0.5 ng of bound anti-LDLR Ab/mg protein), respectively. Twenty-one subjects were LDLR-positive and 22 LDLR-negative. Polyamine levels (nmol/g tissue) were higher in LDLR-positive specimens; this increase was significant for total polyamines (P < 0.05). These findings, reporting the presence of increased polyamine content in LDLR-positive colorectal neoplastic specimens, suggest an association between LDLR levels and gastrointestinal neoplastic proliferative activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8963386     DOI: 10.1007/bf02349635

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  26 in total

1.  ELISA measurement of LDL receptors.

Authors:  K May; F B Kraemer; J Chen; A D Cooper
Journal:  J Lipid Res       Date:  1990-09       Impact factor: 5.922

Review 2.  Polyamine metabolism.

Authors:  N Seiler
Journal:  Digestion       Date:  1990       Impact factor: 3.216

3.  Immunohistochemical localization of low density lipoprotein receptors in adrenal gland, liver, and intestine.

Authors:  L G Fong; E Bonney; J C Kosek; A D Cooper
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

4.  Colon cancer and blood-cholesterol.

Authors:  G Rose; H Blackburn; A Keys; H L Taylor; W B Kannel; O Paul; D D Reid; J Stamler
Journal:  Lancet       Date:  1974-02-09       Impact factor: 79.321

Review 5.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

6.  Metabolism of low-density lipoprotein in differentiated and undifferentiated HT29 colon cancer cells.

Authors:  V Viallard; C Lacombe; V Trocheris; C Tabacik; S Aliau
Journal:  Int J Cancer       Date:  1990-08-15       Impact factor: 7.396

7.  The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E.

Authors:  E E Windler; P T Kovanen; Y S Chao; M S Brown; R J Havel; J L Goldstein
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

8.  Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo.

Authors:  S Vitols; C Peterson; O Larsson; P Holm; B Aberg
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

9.  Demonstration of low density lipoprotein receptor in human colonic carcinoma and surrounding mucosa by immunoenzymatic assay.

Authors:  M G Caruso; M Notarnicola; A Cavallini; V Guerra; G Misciagna; A Di Leo
Journal:  Ital J Gastroenterol       Date:  1993 Aug-Sep

10.  Effect of platelet-derived and endothelial cell-derived growth factors on the low density lipoprotein receptor pathway in cultured human fibroblasts.

Authors:  L D Witte; J A Cornicelli; R W Miller; D S Goodman
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.